Merck (MRK) Goodwill & Intangibles (2009 - 2026)

Merck (MRK) reported Goodwill & Intangibles of $47.3 billion for Q1 2026, up 26.4% year-over-year from $37.4 billion in Q1 2025, and down 1.94% quarter-over-quarter from $48.3 billion in Q4 2025.

Merck (MRK) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Goodwill & Intangibles data on file, last reported at $47.3 billion in Q1 2026.

  • Goodwill & Intangibles for Q1 2026 came in at $47.3 billion, up 26.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.3 billion (up 26.4% YoY), and the FY2025 annual result was $48.3 billion, up 26.87% from the prior year.
  • Goodwill & Intangibles slipped to $47.3 billion in Q1 2026 per MRK's latest filing, from $48.3 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $48.3 billion in Q4 2025 and troughed at $36.8 billion in Q2 2025.
  • A 5-year average of $40.8 billion and a median of $40.4 billion in 2023 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles soared 34.51% in 2022, then decreased 7.26% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $41.5 billion in 2022, then declined by 5.46% to $39.2 billion in 2023, then decreased by 2.98% to $38.0 billion in 2024, then rose by 26.87% to $48.3 billion in 2025, then dropped by 1.94% to $47.3 billion in 2026.
  • Business Quant data shows MRK's Goodwill & Intangibles at $47.3 billion in Q1 2026, $48.3 billion in Q4 2025, and $36.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 47.33 Bn
Dec 31, 2025 48.26 Bn
Sep 30, 2025 36.90 Bn
Jun 30, 2025 36.78 Bn
Mar 31, 2025 37.44 Bn
Dec 31, 2024 38.04 Bn
Sep 30, 2024 38.71 Bn
Jun 30, 2024 38.15 Bn
Mar 31, 2024 38.75 Bn
Dec 31, 2023 39.21 Bn
Sep 30, 2023 40.38 Bn
Jun 30, 2023 40.86 Bn
Mar 31, 2023 41.07 Bn
Dec 31, 2022 41.47 Bn
Sep 30, 2022 42.53 Bn
Jun 30, 2022 43.71 Bn
Mar 31, 2022 44.28 Bn
Dec 31, 2021 44.20 Bn
Sep 30, 2021 32.25 Bn
Jun 30, 2021 32.50 Bn